Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Sep 01, 2021 11:24pm
154 Views
Post# 33799349

RE:I'm getting out of this stock for good!

RE:I'm getting out of this stock for good!

What is the common thread when Thomson invests heavily when they see 4050 to win ownership through recap and then systematically take every indication off the clinical path after being hit with a lawsuit. Coincidence? I'll show you 700 retail investors who would beg to differ. 

BePatient4now wrote:
But I have one question. Why did they kicked out good scientists like Monon and others. Can someone explain please? What was the purpose to do such a thing?

 

<< Previous
Bullboard Posts
Next >>